Guidance

Evidence-based recommendations on QAngio XA 3D QFR and CAAS vFFR imaging software for assessing coronary stenosis during invasive coronary angiography.

Is this guidance up to date?

Next review: 2024

Guidance development process

How we develop NICE diagnostics guidance

This guidance replaces the NICE medtech innovation briefing on QAngio XA 3D/QFR imaging software for assessing coronary obstructions (MIB146).

  • National Institute for Health and Care Excellence (NICE)